EDIT vs. SKX

Last updated Jun 13, 2026

EDIT (Editas Medicine, Inc.) and SKX (Skechers U.S.A., Inc.) are both stocks. EDIT operates in Biotechnology (Healthcare), while SKX operates in Footwear & Accessories (Consumer Cyclical). At a 0.25 correlation, their price movements are largely independent.

Performance

EDIT vs. SKX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Editas Medicine, Inc. (EDIT) and Skechers U.S.A., Inc. (SKX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

EDIT

• 1D: 2.46%
• 1M: -4.58%
• YTD: 21.95%
• 6M: -1.19%
• 1Y: 26.90%
• 3Y*: -39.82%
• 5Y*: -41.79%
• 10Y*: -22.22%

SKX

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

EDIT vs. SKX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
EDIT Editas Medicine, Inc.	21.95%	61.42%	-87.46%	14.21%	-66.59%	-62.13%	136.78%	30.15%	-25.97%	89.34%
SKX Skechers U.S.A., Inc.	0.00%	-6.11%	7.86%	48.61%	-3.34%	20.76%	-16.79%	88.69%	-39.51%	53.95%

Correlation

The correlation between EDIT and SKX is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.22
Correlation (5Y) Calculated over the trailing 5-year period	0.30
Correlation (10Y) Calculated over the trailing 10-year period	0.26
Correlation (All Time) Calculated using the full available price history since Feb 3, 2016	0.25

Over the past year, the correlation between EDIT and SKX has dropped to 0.02 - well below their long-term average of 0.25, suggesting their price drivers have been diverging.

Fundamentals

Market Cap EDIT : $244.70M SKX : $9.55B
EPS EDIT : -$1.21 SKX : $4.40
PS Ratio EDIT : 6.29 SKX : 1.01
PB Ratio EDIT : 55.51 SKX : 2.00
Total Revenue (TTM) EDIT : $35.86M SKX : $9.41B
Gross Profit (TTM) EDIT : $35.86M SKX : $4.96B
EBITDA (TTM) EDIT : -$76.66M SKX : $1.07B

Return for Risk

EDIT vs. SKX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EDIT

EDIT Risk / Return Rank: 51
EDIT Sharpe Ratio Rank: 48
EDIT Sortino Ratio Rank: 56
EDIT Omega Ratio Rank: 53
EDIT Calmar Ratio Rank: 49
EDIT Martin Ratio Rank: 48

SKX

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EDIT vs. SKX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Editas Medicine, Inc. (EDIT) and Skechers U.S.A., Inc. (SKX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	EDIT	SKX	Difference
Sharpe ratio: Return per unit of total volatility	0.16	—	—
Sortino ratio: Return per unit of downside risk	0.98	—	—
Omega ratio: Gain probability vs. loss probability	1.11	—	—
Calmar ratio: Return relative to maximum drawdown	0.25	—	—
Martin ratio: Return relative to average drawdown	0.43	—	—

Drawdowns

Drawdown Indicators

	EDIT	SKX	Difference
Max Drawdown Largest peak-to-trough decline	-98.92%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-59.88%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-91.18%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-98.66%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-98.92%	—	—
Current Drawdown Current decline from peak	-97.24%	—	—
Average Drawdown Average peak-to-trough decline	-62.63%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	34.03%	—	—

Volatility

Volatility by Period

	EDIT	SKX	Difference
Volatility (1M) Calculated over the trailing 1-month period	32.34%	—	—
Volatility (6M) Calculated over the trailing 6-month period	61.63%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	94.75%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	94.12%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	83.80%	—	—

Dividends

EDIT vs. SKX - Dividend Comparison

Neither EDIT nor SKX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both EDIT and SKX in my portfolio?

EDIT and SKX have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.